Skip to main content
. 2014 Oct 31;7:768. doi: 10.1186/1756-0500-7-768

Table 3.

VEGF genotype in sporadic colorectal cancer patients stratified according to clinical characteristics

Clinical characteristics Number of patients (%) C936T VEGF polymorphism
CC (%) CT + TT (%) P value
Mean age at diagnosis 261 64.9 65.8
Ethnic origin 261
Caucasian 219 (84,9) 173 (66,3) 46 (17,6) 0.4693
African-American 42 (16,1) 33 (12,6) 9 (3,4)
Metastasis 261 0.7843
No 211 (80,8) 166 (63,6) 45 (17,2)
Yes 50 (19,2) 40 (15,3) 10 (3,8)
Survival 0.2619
≥ 5 years 147 112 (76,2) 35 (23,8)
Regional lymph node 165
N+ 80 (48,5) 64 (38,8) 16 (9,7) 0.8485
N0 85 (51,5) 69 (41,8) 16 (9,7)
Infiltration 165
Tis-T2 39 (23,6) 31 (18,8) 8 (4,8) 0.9408
T3-T4 126 (76,4) 102 (61,8) 24 (14,5)
Tumor location 260
Rectum 137 (52,7) 106 (41,1) 29 (11,2) 0.3116
Left Colon 79 (30,4) 60 (23,3) 19 (7,4)
Right Colon 44 (16,9) 39 (15,1) 5 (1,9)
TNM 226 0.6045
I + II 139 (61,5) 109 (48,2) 30 (13,3)
III + IV 87 (38,5) 69 (30,5) 18 (8)